TIME Is Looking For the World's Top HealthTech Companies of 2026
TIME will publish its second annual World's Top HealthTech Companies ranking in September 2026, partnering with market‑data firm Statista. The list will spotlight firms that advance digital health, telemedicine, AI‑driven diagnostics, medical devices, and health‑data analytics. Companies can submit applications until June 14, 2026, though submission does not guarantee a spot. The initiative aims to highlight innovators that improve accessibility, efficiency, and sustainability across the global healthcare system.
IPSC Tissues Supply Causal Data to Power Simulations
A general-purpose biological simulator, one that can predict how the human body responds to any intervention, isn't blocked by compute. It's blocked by data. Not data in general. Causal, human-relevant data. The kind where molecular interactions actually produce functional outcomes you...
When AI Gets Health Questions Wrong
A BMJ Open audit of five popular AI chatbots—Gemini, DeepSeek, Meta AI, ChatGPT and Grok—found that nearly half of their health‑related answers were problematic, with 19.6% rated highly problematic. The study tested 50 prompts across cancer, vaccines, stem cells, nutrition...
Real-World Evoque Data Reassure, but It’s Still Early Days With TTVR
Early US real‑world data from the TVT Registry show that transcatheter tricuspid valve replacement (TTVR) with Edwards' Evoque device matches or modestly exceeds outcomes from the pivotal TRISCEND II trial. In 1,034 patients (average age 77, 69% female) 30‑day mortality was...
QT Imaging, Olea Medical Introduce New Viewer for Integrated, Multimodality Breast Imaging
QT Imaging Holdings and Olea Medical have launched the QTI Imaging‑Olea Viewer, a unified platform that merges QTscan acoustic CT data with mammography, digital breast tomosynthesis, MRI and ultrasound. The viewer delivers 3‑D volumetric imaging without ionizing radiation, targeting dense‑breast...
CRISPR Variant Selectively Targets Tumor DNA
Researchers at Van Andel Institute and Wageningen University have engineered a CRISPR variant, ThermoCas9, that reads DNA methylation patterns to differentiate tumor DNA from healthy DNA. The enzyme selectively cuts methylated cancer sequences while sparing unmethylated normal genes, a finding published...
Breath Carries Clues to Gut Health
Consumer‑grade breath analyzers such as the Trio‑Smart and FoodMarble AIRE now let users sample exhaled gases at home, promising insights into gut health. While clinicians rely on standardized breath tests—measuring hydrogen and methane after a sugar solution—to diagnose conditions like...
Rapid Melatonin Test Can Help Astronauts and Others Easily Monitor Their Biological Rhythm
Washington State University researchers have created a 15‑minute melatonin test that combines a paper‑strip assay with a 3D‑printed smartphone fluorescence reader. The lateral‑flow immunoassay uses europium nanoparticles to achieve laboratory‑grade sensitivity of 10 picograms per milliliter, pinpointing the onset of an...
Abridge Incorporates More Clinical Evidence Into Its Decision Support Tools
Abridge announced multiyear partnerships with the New England Journal of Medicine and the JAMA Network, adding their peer‑reviewed research to its AI‑driven clinical decision‑support platform. The new content will join existing UpToDate data, allowing the system to surface evidence‑based answers...
TOBY Gets FDA Breakthrough Device Designation for Urine-Based Multi-Cancer Test
TOBY, Inc., a Texas biotech firm, earned FDA Breakthrough Device Designation for its urine‑based multi‑cancer early detection (MCED) test. The designation accelerates clinical validation and could reshape non‑invasive cancer screening.
MiniMed Flexes with Next-Gen Insulin Pump After Spinning Off From Medtronic
MiniMed, the newly independent diabetes business spun out of Medtronic, secured FDA clearance for its next‑generation MiniMed Flex insulin pump within two weeks of its March 2026 IPO. The Flex is a screenless, pocket‑sized device that retains the 300‑unit reservoir...
Graphene‑Oxide Nanoplatform Merges Proteasome Inhibition and Phototherapy for Oral Cancer
Scientists have introduced a graphene‑oxide‑based nanoplatform that simultaneously delivers proteasome inhibitors and phototherapy to oral cancer cells. Preclinical tests indicate the combined approach outperforms each modality alone, offering a potential route to more precise, less toxic treatment.
One Health System CIO's Vision for Harnessing AI with Cybersecurity
Catawba Valley Health System’s CIO Nadin Knippschild says the organization must harness AI to improve efficiency while simultaneously strengthening cybersecurity as it moves more services to the cloud. She notes that nearly 37% of U.S. hospitals operate at a loss...
The Clinical Resolution Gap: Why AI Can’t Fix Broken MSK Care Platforms
AI is reshaping musculoskeletal (MSK) care by automating documentation and triage, yet it largely fixes workflow rather than patient outcomes. Digital platforms tout engagement metrics—logins, exercise completion, chat usage—while employers care about episode duration, surgery avoidance, and total cost of...
Signal Labs: Building Attention Infrastructure
Lightspeed Venture Partners announced it will lead the Series Seed round for Signal Labs, a startup founded by former Elevance Health and Lyric executive Raj Ronanki. The company is creating an AI‑first “attention infrastructure” that coordinates high‑volume healthcare payment signals—claims,...
A Global Breakthrough in Interventional Imaging Fully Made in France
GE HealthCare’s Allia™ Moveo interventional imaging system received FDA clearance and CE marking in December 2025, marking the first fully French‑made, cable‑free mobile C‑arm platform. The device combines a lightweight composite C‑arm, concealed cabling and AI‑enhanced 3‑D reconstruction to free...
Ambience Unveils Multi-Year Roadmap to ‘Rebuild’ Healthcare with AI
Ambience Healthcare announced a multi‑year AI platform roadmap at its Apex Summit, shifting focus from documentation automation to a comprehensive intelligence layer across clinical, revenue and research workflows. The company, fresh from a $243 million Series C that lifted its valuation to...
AI Can Help Close the Medication Information Gap
ChristianaCare is piloting artificial‑intelligence tools to translate complex medication instructions into patient‑friendly language. Director of patient education Greg O'Neill says the AI‑generated messages provide clear dosing steps, side‑effect warnings, and adherence cues. The technology integrates with the health system’s electronic...
Implications of AI Chatbots Performing Poorly at Differential Diagnosis
A follow‑up study of 21 large language models shows they can deliver accurate final diagnoses when supplied with complete clinical data, but they falter at generating differential diagnoses with limited information. The researchers introduced the PrIME‑LLM metric, which scores models...
Elucid Announces Commercial Availability of Lesion Inspection Tool for Plaque-IQ™
Elucid announced the commercial launch of a Lesion Inspection Tool within its Plaque‑IQ software, enabling physicians to quantify plaque composition at the individual lesion level in coronary and carotid arteries. The tool provides quantitative data on high‑risk features such as...
Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries
Precision BioSciences received Clinical Trial Application approval to add sites in France and Romania to its global ELIMINATE‑B study of PBGENE‑HBV, an in‑vivo gene‑editing therapy for chronic hepatitis B. The expansion joins existing locations in the United Kingdom, Moldova, New Zealand, Hong Kong...
From Insight to Intervention: Why Over-the-Counter Digital Therapeutics (ODTx) Are the Next Step for LLMs and Wearables
Over‑the‑counter digital therapeutics (ODTx) are emerging as a regulated, consumer‑accessible bridge between data‑rich wearables, AI‑driven language models and clinically proven treatment. Unlike wellness apps, ODTx are classified as software‑as‑a‑medical‑device and must secure FDA authorization, allowing them to make evidence‑based therapeutic...
The Last Mile Problem in AI Radiology: Detection Improves, Follow-Through Breaks
AI tools are dramatically improving the detection of pulmonary nodules and other incidental findings in radiology, but hospitals struggle to translate those alerts into completed follow‑up exams. The handoff chain—from radiology report to electronic health record order, scheduling, and final...
KA Imaging Expands Global Footprint
KA Imaging announced regulatory approvals for its Reveal Mobi Pro and Mobi Lite mobile X‑ray systems in Hong Kong and Australia, expanding its clinical footprint in Asia‑Pacific. The company also launched a partnership with Scintica to deliver its 3‑D X‑ray platform to North...
CMS Establishes New Billing Code for AI-Driven Calcium Analysis on CT Scans
The Centers for Medicare & Medicaid Services (CMS) announced a new national billing code under the Hospital Outpatient Prospective Payment System, effective April 1, 2026, for AI-driven analysis of coronary artery calcium (CAC) and aortic valve calcium (AVC) on chest CT scans....
Novo Nordisk Teams Up with OpenAI to Fast‑Track Obesity Drug Development
Novo Nordisk announced a strategic partnership with OpenAI to embed advanced AI across its research pipeline, aiming to shorten development time for obesity and diabetes treatments. The deal, disclosed on April 14, sent Novo’s shares up 2.8% and underscores a...
Teva Launches “Home Ground” Online Resource for People Living with Schizophrenia and Their Care Partners
Teva Pharmaceuticals has launched Home Ground, a free online community for people living with schizophrenia and their care partners. The platform, built with input from patients and caregivers, offers symptom‑tracking worksheets, emotional‑wellness videos, independent‑living toolkits, physical‑health checklists, and both virtual...
Briya Hits 120m Patient Journeys Milestone
Briya announced its global data network now spans over 120 million patient journeys, integrating records from the United States, European Union, Latin America, the United Kingdom, Asia and the Middle East. The expansion adds 3 million UK longitudinal records and broadens its...
Video Wednesday
Flickstop’s blog showcases two image‑only posts from 2020 and 2021 that highlight the company’s work in medical robotics—one depicting a robotic surgery and another illustrating an autonomous pandemic‑response robot. The latest entry, titled “Video Wednesday” on April 15, 2026, contains no text...
Oncology Innovation Outpaces Managed Care’s Ability to Keep Up
Rapid advances in precision oncology are outpacing managed‑care systems, leaving gaps in biomarker testing, pharmacogenomics, CAR‑T access, and clinical pathway adherence. A study showed only 35.6% of eligible NSCLC patients receive targeted therapy, while DPYD testing—costing $175—could prevent $180,000‑plus in...
Six Tailored Keynote Narratives Shaping Healthcare's Future
This conference season, I work with six keynote narratives. I still customize each for every single event and audience, but the narratives (that I work on with a dedicated team for months) help tell a powerful story. Here they are: 01...
New Study on AI Clinical Decision-Making
A recent study evaluated large language model (LLM) AIs across 29 clinical vignettes, generating 16,254 responses. Scores ranged from 0.64 for Gemini 1.5 Flash to 0.78 for Grok 4, with GPT models leading overall. While final‑diagnosis accuracy was modest, failure rates for differential...
MRNA Nanoparticles Teach Beta Cells to Prevent Type 1 Diabetes
As a medical school professor, I can tell you: what we've been doing for type 1 diabetes is managing, not curing. University of Chicago scientists just changed the game. They developed mRNA-loaded nanoparticles that deliver genetic instructions directly to insulin-producing beta cells,...
New Market Map Highlights Agentic AI in Ambulatory Sector
Market maps have become a real focus of ours as LLMs are getting company categorization so wrong. Our latest, in partnership with Confido Health & @RMFnyc1, focuses on agentic AI for the ambulatory market. What's being deployed now? Our focus...
The Solar-Powered Medical Kiosks Bringing Doctors to Remote Chadians
Telemedan, founded in 2021 by Abakar Mahamat and Ahmed Kotoko, deploys solar‑powered medical kiosks that link rural Chadians to qualified doctors via video and on‑site diagnostic tools. Each $10,000 unit is sold to governments or public health programs, offering consultations...
Medical AI Flaws Exposed: Bad Chatbot Answers, Unreliable Data
Issues recognized with medical AI models —Problematic responses to 5 chatbots https://t.co/V6IZHOhAm4 —Prediction based on unreliable, open-access datasets https://t.co/PnJ0TrtXK2 https://t.co/Bp8ztckFgV
AI Agents and Next‑Gen Alzheimer’s Drugs Beyond CRISPR
Endpoints' Drug Discovery Day is today — our own @RLCscienceboss will be talking about beyond CRISPR & future of Alzheimer's drugs I'm excited to talk with Stanford's @james_y_zou on his escalating research in building AI agents into co-scientists, labs, and now biotechs...
Hospital at Home Evaluation Shows 80 Percent Cost Savings at West Hertfordshire Teaching Hospitals
West Hertfordshire Teaching Hospitals reported an 80% cost reduction for its Hospital at Home (HAH) program, saving £1.33 million (~$1.7 million) over a 12‑month period. The virtual care model cost $150 per bed day versus $723 for inpatient stays, cutting average length...
American Academy of Nursing Issues Comprehensive AI Position Statement
On Feb. 25, 2026 the American Academy of Nursing (AAN) approved a comprehensive AI position statement that frames artificial intelligence as a collaborative tool to augment, not replace, nursing judgment. Developed by the Academy’s AI Taskforce, the document outlines 13 policy recommendations...
A Blunt Assessment of Every Major ACCESS Model Participant, Their Business Models, and What CMS’s New Outcome-Aligned Payment Framework Actually...
The CMS Innovation Center’s ACCESS Model launches July 5, 2026, testing an Outcome‑Aligned Payment (OAP) system for chronic‑care management across cardiometabolic, musculoskeletal and behavioral‑health tracks. Participants receive monthly fixed per‑patient payments, with half withheld until a 12‑month reconciliation that depends on meeting...
Liverpool University Hospitals Announces 10-Year EPR Supplier
Liverpool University Hospitals NHS Foundation Trust has inked a 10‑year, £53 million (~$68 million) agreement with Nervecentre to deploy its electronic patient record (EPR) across Aintree, Broadgreen and Royal Liverpool hospitals. The deal brings roughly 1,600 beds onto a single, integrated digital...
TOBY Secures US FDA Breakthrough Device Designation for Urine-Based Multi-Cancer Test
TOBY has received FDA Breakthrough Device Designation for its urine‑based Multi‑Cancer Early Detection (MCED) test. The non‑invasive platform analyzes volatile organic compounds in a single urine sample using spectroscopy and machine‑learning algorithms to identify multiple cancer types. The designation positions...
Anthropic's IPO Play, Novo Nordisk X OpenAI, and the First Brain Sensor Goes Human
The episode covers a rapid round‑up of AI‑related headlines: Apple is testing four frame designs for smart glasses that will focus on camera, call, and AI assistant functions rather than AR; Vercel’s CEO announced a surge to a $340 million ARR...
Enhancing Oxidase‐Catalyzed Biosensing via Hydrophobic ZIF‐7 Nanomaterials: A Micro‐Triphase Interface Approach
The study introduces ZIF-7 nanoparticles as hydrophobic oxygen reservoirs in a solid–liquid–air triphase enzyme electrode, boosting oxidase‑catalyzed biosensing. By releasing pre‑stored O₂, the system raises Vmax 21‑fold and widens the glucose linear range from 2 mM to 20 mM, a ten‑fold improvement...
Tumor Microenvironment‐Responsive Dual‐Enzymatic Flasklike Nanobots for Enhanced Chemotherapy
Researchers have engineered a flask‑shaped nanobot (GC‑M@FPNbot) that harnesses glucose oxidase and catalase to self‑propel in response to tumor‑specific proton and hydrogen peroxide gradients. Loaded with doxorubicin, the bots exhibit chemotactic motion that enables deep penetration of extracellular matrix and...
Atelerix Forms Strategic Partnership With JH Health Ltd to Expand Non-Cryogenic Cell Preservation Capabilities in the Middle East
Atelerix, a UK biotech, has signed a strategic partnership with Saudi Arabia’s JH Health Ltd, granting JH Health exclusive rights to distribute Atelerix’s non‑cryogenic hydrogel cell‑preservation solutions across the Middle East. The deal includes funding for high‑volume local manufacturing, regulatory...
Navigated TMS Cuts Combat PTSD Symptoms for 85% in Landmark Trial
Researchers at UT Health San Antonio reported that a patented, MRI‑guided, robotic transcranial magnetic stimulation (TMS) protocol reduced PTSD symptoms in 85% of combat‑exposed service members and veterans when combined with intensive psychotherapy. The randomized trial, published in JAMA Network...
StuffThatWorks Launches Research Fellows Programme
StuffThatWorks has launched a Research Fellows Program that grants ten non‑profit researchers unrestricted, free access to its massive patient‑reported real‑world dataset, which contains over 1.3 billion data points across 1,250 conditions. The program supplies SNOMED‑compatible, IRB‑approved data, built‑in analytics tools, and...
I Sold My Startup A Year After Founding It. Here’s Why That Was The Fastest Way To Build Real-World Healthcare...
Louis Blankemeier co‑founded Cognita to turn Stanford‑level radiology AI into a clinical product. Within a year, the team sold the startup to Radiology Partners, the world’s largest radiology practice, to gain scale, data access, and regulatory pathways. The acquisition enables...
Eliud Kipchoge Backs Huawei Wearables that Flag Injury Risk in Real Time
Olympic marathon champion Eliud Kipchoge, Huawei’s global brand ambassador, explained how the company’s smartwatches use real‑time biometrics to spot fatigue before it turns into injury and to reinforce daily health habits. The interview underscores a shift toward data‑driven, personalized training...